Annual Debt To Equity
-0.57
+0.23+28.75%
31 December 2023
Summary:
Esperion Therapeutics annual debt to equity ratio is currently -0.57, with the most recent change of +0.23 (+28.75%) on 31 December 2023. During the last 3 years, it has risen by +1.30 (+69.52%). ESPR annual debt to equity is now -157.58% below its all-time high of 0.99, reached on 31 December 1999.ESPR Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Debt To Equity
-0.71
+0.05+6.58%
30 September 2024
Summary:
Esperion Therapeutics quarterly debt to equity ratio is currently -0.71, with the most recent change of +0.05 (+6.58%) on 30 September 2024. Over the past year, it has dropped by -0.07 (-10.94%). ESPR quarterly debt to equity is now -810.00% below its all-time high of 0.10, reached on 30 September 2014.ESPR Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESPR Debt To Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +28.8% | -10.9% |
| 3 y3 years | +69.5% | +5.3% |
| 5 y5 years | -100.0% | -100.0% |
ESPR Debt To Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +69.5% | -24.6% | +45.8% |
| 5 y | 5 years | +69.5% | +62.0% | ||
| alltime | all time | -157.6% | +69.5% | -810.0% | +62.0% |
Esperion Therapeutics Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -0.71(-6.6%) |
| June 2024 | - | -0.76(-14.6%) |
| Mar 2024 | - | -0.89(+56.1%) |
| Dec 2023 | -0.57(-28.7%) | -0.57(-10.9%) |
| Sept 2023 | - | -0.64(-8.6%) |
| June 2023 | - | -0.70(-11.4%) |
| Mar 2023 | - | -0.79(-1.3%) |
| Dec 2022 | -0.80(-38.9%) | -0.80(-9.1%) |
| Sept 2022 | - | -0.88(-1.1%) |
| June 2022 | - | -0.89(-14.4%) |
| Mar 2022 | - | -1.04(-20.6%) |
| Dec 2021 | -1.31(-29.9%) | -1.31(+74.7%) |
| Sept 2021 | - | -0.75(-15.7%) |
| June 2021 | - | -0.89(-11.9%) |
| Mar 2021 | - | -1.01(-46.0%) |
| Dec 2020 | -1.87(<-9900.0%) | -1.87(<-9900.0%) |
| Sept 2020 | - | 0.00(0.0%) |
| June 2020 | - | 0.00(0.0%) |
| Mar 2020 | - | 0.00(0.0%) |
| Dec 2019 | 0.00(0.0%) | 0.00(0.0%) |
| Sept 2019 | - | 0.00(0.0%) |
| June 2019 | - | 0.00(0.0%) |
| Mar 2019 | - | 0.00(0.0%) |
| Dec 2018 | 0.00 | 0.00(0.0%) |
| Sept 2018 | - | 0.00(0.0%) |
| June 2018 | - | 0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | 0.00(0.0%) |
| Dec 2017 | 0.00(-100.0%) | 0.00(-100.0%) |
| Sept 2017 | - | 0.01(0.0%) |
| June 2017 | - | 0.01(0.0%) |
| Mar 2017 | - | 0.01(0.0%) |
| Dec 2016 | 0.01(0.0%) | 0.01(0.0%) |
| Sept 2016 | - | 0.01(0.0%) |
| June 2016 | - | 0.01(0.0%) |
| Mar 2016 | - | 0.01(0.0%) |
| Dec 2015 | 0.01(-75.0%) | 0.01(-50.0%) |
| Sept 2015 | - | 0.02(0.0%) |
| June 2015 | - | 0.02(0.0%) |
| Mar 2015 | - | 0.02(-50.0%) |
| Dec 2014 | 0.04(>+9900.0%) | 0.04(-60.0%) |
| Sept 2014 | - | 0.10(+25.0%) |
| June 2014 | - | 0.08(>+9900.0%) |
| Mar 2014 | - | 0.00(0.0%) |
| Dec 2013 | 0.00(-100.0%) | 0.00(0.0%) |
| Sept 2013 | - | 0.00(0.0%) |
| June 2013 | - | 0.00(0.0%) |
| Mar 2013 | - | 0.00(-100.0%) |
| Dec 2012 | -1.31(+14.9%) | -1.31 |
| Dec 2011 | -1.14(-595.7%) | - |
| Dec 2002 | 0.23(+130.0%) | - |
| Dec 2001 | 0.10(+66.7%) | - |
| Dec 2000 | 0.06(-93.9%) | - |
| Dec 1999 | 0.99 | - |
FAQ
- What is Esperion Therapeutics annual debt to equity ratio?
- What is the all time high annual debt to equity for Esperion Therapeutics?
- What is Esperion Therapeutics annual debt to equity year-on-year change?
- What is Esperion Therapeutics quarterly debt to equity ratio?
- What is the all time high quarterly debt to equity for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly debt to equity year-on-year change?
What is Esperion Therapeutics annual debt to equity ratio?
The current annual debt to equity of ESPR is -0.57
What is the all time high annual debt to equity for Esperion Therapeutics?
Esperion Therapeutics all-time high annual debt to equity ratio is 0.99
What is Esperion Therapeutics annual debt to equity year-on-year change?
Over the past year, ESPR annual debt to equity ratio has changed by +0.23 (+28.75%)
What is Esperion Therapeutics quarterly debt to equity ratio?
The current quarterly debt to equity of ESPR is -0.71
What is the all time high quarterly debt to equity for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly debt to equity ratio is 0.10
What is Esperion Therapeutics quarterly debt to equity year-on-year change?
Over the past year, ESPR quarterly debt to equity ratio has changed by -0.07 (-10.94%)